Beijing, China

Haifan Liu

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Chinese Academy of Medical Sciences. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Haifan Liu. Retrieved from https://idiyas.com/inventor/haifan-liu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile



Average Co-Inventor Count = 11.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Haifan Liu: Innovator in Pharmaceutical Science

Introduction

Haifan Liu is a prominent inventor based in Beijing, China. He has made significant contributions to the field of pharmaceutical science, particularly through his innovative research and development of new compounds.

Latest Patents

Haifan Liu holds a patent for "Agarofuan derivatives, their preparation, pharmaceutical composition containing them and their use as medicine." This patent describes a compound represented by a specific formula, detailing the substitutes defined in the specification and claims, as well as their stereoisomers. The patent also outlines the process for preparing these compounds, the pharmaceutical compositions that contain them, and their applications in medicine. He has 1 patent to his name.

Career Highlights

Liu is affiliated with the Chinese Academy of Medical Sciences, where he conducts his research. His work focuses on the development of pharmaceutical solutions that can potentially improve health outcomes.

Collaborations

Throughout his career, Haifan Liu has collaborated with notable colleagues, including Jiyu Guo and Weijun Wang. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Haifan Liu's contributions to pharmaceutical science through his innovative patents highlight his role as a key inventor in the field. His work continues to influence medical research and development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…